
Icons Of Whiskey: George T. Stagg— Bourbon's Visionary
George T. Stagg is a legendary and influential figure in American whiskey history—a towering presence, both literally and figuratively, in the 19th-century bourbon industry. Stagg's name, now linked with quality and innovation, also serves as the brand for one of America's premium whiskeys. From humble beginnings to his transformative role in one of Kentucky's most iconic industries, Stagg's influence continues to resonate today, making him an Icon of Whiskey.
George Thomas Stagg was born in 1835 in Garrard County, near Lancaster, Kentucky. Little is known about his early years. He married Elizabeth Doolan in 1858. The couple settled in Richmond, Kentucky, where George was employed as a traveling shoe salesman.
When the Civil War broke out in 1861, George enlisted in the Union Army, serving in the 21st Kentucky Infantry Regiment. He rose from enlisted man to the rank of Captain. In 1863, he was appointed an Aide-de-Camp to General Ambrose Burnside.
In 1865, following the end of the war, he relocated to St. Louis, Missouri, and began his career in the whiskey industry. Stagg formed a partnership with James Gregory, creating Gregory & Stagg, Commercial Merchants & Distillers' Agents.
A bottle of George T Stagg, Kentucky Straight Bourbon Whiskey Photo, courtesy Buffalo Trace Distillery
In the late 1860s, Stagg's growing interest in the bourbon business led him to Frankfort, Kentucky, the heart of bourbon country where he forged a relationship with E.H. Taylor, Jr. Taylor was a key figure in the bourbon industry and founder of the O.F.C. Distillery (Old Fire Copper) and the adjacent Carlisle Distillery.
Taylor was a brilliant distiller but had recurring financial difficulties due to the capital-intensive nature of whiskey production. His financial problems were aggravated by a nationwide economic downturn in 1873. In 1877, Taylor declared bankruptcy, prompting Stagg and Gregory to step in as financiers and partners.
When Taylor was forced to sell the two distilleries in 1878, Stagg organized the E.H. Taylor Jr company to acquire them. He retained approximately 70% of the stock in the new company and distributed the remaining balance to Taylor. Stagg was appointed president, and Taylor vice president and head distiller.
Under Stagg's ownership, the distillery flourished, experiencing significant growth. He modernized operations, expanding production capacity and implementing cutting-edge technologies, such as steam heating of the warehouses.
Stagg's warehouses were the first climate-controlled facilities for aging bourbon in the US. He also developed an efficient and scalable aging process, improved record-keeping and quality control standards, thereby creating the consistency that consumers expected in premium bourbon.
He continued producing the O.F.C. Bourbon brand. After Prohibition, the brand name was changed to Old Stagg.
Taylor had a contentious relationship with Stagg. In 1886, Taylor left the company, trading his shares for ownership of another distillery that Stagg had acquired. That distillery would become the Old Taylor Distillery. In 1890, the company's name was changed to George T. Stagg & Company. In 1904, it was changed again to The George T Stagg Distillery.
Stagg was a key player in shaping the post-Civil War bourbon industry. He helped transform bourbon from a regional product into a nationally recognized spirit by establishing an extensive distribution network, particularly in the Midwest and South. His knack for sales and logistics, paired with Kentucky's reputation for quality whiskey, proved an unbeatable combination. The Stagg Distillery's Legacy
The George T. Stagg Distillery was one of the most modern and well-regarded whiskey operations in Kentucky by the late 19th century. Though Stagg died in 1893, at the relatively young age of 58, his name remained closely associated with the distillery. In the early 20th century, the distillery overcame significant financial challenges. They survived Prohibition by obtaining one of only six licenses in the U.S. to sell 'medicinal whiskey.'
In the decades following Stagg's death, the distillery changed hands and names several times. By the mid-20th century, it became part of the Ancient Age Distillery. Then, in 1992, it was purchased by Buffalo Trace Distillery, a subsidiary of the Sazerac Company. Recognizing the rich history of the site and its historical figures, Buffalo Trace would go on to revitalize its legacy brands, including one that would cement George T. Stagg's name in whiskey lore.
The Buffalo Trace Distillery was once known as the George T Stagg distillery. Photo, courtesy Buffalo Trace Distillery The George T. Stagg Brand and Buffalo Trace Distillery
In 2002, the Buffalo Trace Distillery released a high-proof, unfiltered bourbon named George T. Stagg. It was part of its Buffalo Trace Antique Collection (BTAC). This release was meant to honor Stagg's enduring impact on the industry and his contributions to the success of the historic distillery.
Each fall, the George T. Stagg bourbon is released in limited quantities, aged for 15 to 19 years, and bottled at barrel proof (often above 120 proof). It quickly gained a cult following among whiskey enthusiasts, winning numerous awards, including 'World's Best North American Whiskey' and frequent placements in Jim Murray's Whisky Bible . It has also been a consistent medalist at international spirit competitions.
Buffalo Trace's Stagg bourbon is robust, with a layered complexity that features dark cherry, leather, molasses, and charred oak. It's bold and rich on the palate, with layers of vanilla, brown sugar, dark chocolate, and baking spice. The finish is long and intense with a smoky sweetness.
Its limited availability and high quality have made it a sought-after bottle on the secondary market, often fetching prices many times above its official retail cost.
Today, the distillery once known as the George T. Stagg Distillery operates as Buffalo Trace Distillery, located in Frankfort, Kentucky. It is one of the oldest continually operating distilleries in the United States and has received countless accolades for its production excellence and preservation of bourbon heritage.
The distillery is owned by the Sazerac Company, a privately held American alcoholic beverage company headquartered in New Orleans. Sazerac has embraced the history of its properties, including honoring figures like George T. Stagg and E.H. Taylor Jr. with dedicated labels in its prestigious lineup.
Buffalo Trace produces a range of other highly regarded whiskies, including Buffalo Trace Bourbon, Eagle Rare, Blanton's, E.H. Taylor Small Batch, and Stagg Jr. The latter, now called Stagg, is a more accessible companion to George T. Stagg bourbon. Legacy and Influence
George T. Stagg may have lived in the 19th century, but his influence continues to shape the bourbon industry in the 21st century. He exemplified the importance of marrying sound business management with a commitment to quality. That professionalism is now a trademark of the American whiskey industry.
His name, once affixed to a Kentucky distillery, now stands for bold, uncompromising bourbon that has helped usher American whiskey's modern revival. The annual release of George T. Stagg bourbon remains a benchmark event for collectors and connoisseurs alike. It pays homage to a man whose vision transformed a regional spirit into a national treasure.
Though not well known outside whiskey circles, George Stagg's legacy is monumental. Without his foresight and investment, one of Kentucky's most storied distilleries might never have survived the 19th century. Thanks to him and the modern revival of his name as a whiskey brand, Stagg remains an enduring symbol of American whiskey excellence and a true Icon of Whiskey. More From Forbes Forbes Icons Of Whiskey: Elijah Craig — The Father Of Bourbon By Joseph V Micallef Forbes Icons Of Whiskey: Jacob Beam's Bourbon Dynasty By Joseph V Micallef Forbes America's Top-Rated Wheated Bourbons And Whiskeys: Smooth, Bold And Affordable By Joseph V Micallef
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Philip Morris Stock Outlook: Is Wall Street Bullish or Bearish?
With a market cap of $253.7 billion, Philip Morris International Inc. (PM) is a global tobacco company focused on delivering a smoke-free future. Its product portfolio includes traditional cigarettes, smoke-free alternatives like IQOS and ZYN, and expanding offerings in wellness and healthcare. Shares of the Stamford, Connecticut-based company have outperformed the broader market over the past 52 weeks. PM stock has surged 38.3% over this time frame, while the broader S&P 500 Index ($SPX) has gained 18.4%. Moreover, shares of Philip Morris are up 35.4% on a YTD basis, compared to SPX's 7.6% increase. More News from Barchart Dear Nvidia Stock Fans, Mark Your Calendars for August 27 Options Traders Expected Palantir Stock's Tamest Earnings Reaction in a Year. Did They Get It Right? Tesla Gains on Elon Musk's New Pay Package. Is TSLA Stock a Buy? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Narrowing the focus, the tobacco giant stock has also outpaced the Consumer Staples Select Sector SPDR Fund's (XLP) 1.6% rise over the past 52 weeks. Despite reporting a better-than-expected Q2 2025 adjusted EPS of $1.91, shares of Philip Morris tumbled 8.4% on Jul. 22. Total sales rose 7.1% to $10.1 billion and ZYN shipments came in at 190 million cans, both missing analysts' estimates. For the fiscal year ending in December 2025, analysts expect PM's adjusted EPS to grow 14.3% year-over-year to $7.51. The company's earnings surprise history is promising. It beat the consensus estimates in the last four quarters. Among the 14 analysts covering the stock, the consensus rating is a 'Strong Buy.' That's based on nine 'Strong Buy' ratings, two 'Moderate Buys,' and three 'Holds.' On Jul. 14, UBS maintained its 'Neutral' rating on Philip Morris but raised its price target to $181, citing strong smoke-free margin growth driven by IQOS and ZYN, with robust U.S. volume projections and revised earnings estimates through 2027. As of writing, the stock is trading below the mean price target of $193.38. The Street-high price target of $220 implies a potential upside of nearly 35% from the current price. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 minutes ago
- Yahoo
Alcon Expands Vision Correction Portfolio With STAAR Surgical Acquisition
On Tuesday, the eye care company Alcon Plc (NYSE:ALC) agreed to acquire STAAR Surgical Company (NASDAQ:STAA), the manufacturer of the implantable collamer lens (ICL). The acquisition includes the EVO family of lenses (EVO ICL) for vision correction for patients with moderate to high myopia (nearsightedness), with or without astigmatism. Alcon will purchase all outstanding shares of STAAR common stock for $28 per share in cash, which represents approximately a 59% premium to STAAR's 90-day Volume Weighted Average Price (VWAP) and a 51% premium to the closing price of STAAR common stock on August 4, transaction represents a total equity value of approximately $1.5 billion. Alcon intends to finance the transaction by issuing short- and long-term credit facilities. The transaction is anticipated to close in approximately six to 12 months and is expected to be accretive to earnings in year two. 'With the number of high myopes rising globally, the acquisition of STAAR enhances our ability to offer a leading surgical vision correction solution for those who are not ideal candidates for other refractive surgeries such as LASIK,' said David Endicott, CEO of Alcon. An estimated 50% of the world will be myopic by 2050, and today, nearly 500 million people are considered high myopes. The EVO family of ICLs are implanted between the iris (the colored part of the eye) and the natural crystalline lens during a procedure that does not remove corneal tissue. This move follows Alcon's recent announcement in July regarding its intention to acquire LumiThera, Inc. and its Photobiomodulation (PBM) Device for dry age-related macular degeneration (AMD). Data from the LIGHTSITE I, II, and III clinical trials consistently showed that PBM treatments provide visual acuity improvement with no treatment-related serious adverse events reported. PBM received FDA de novo market authorization in November 2024 and CE Mark in November 2018. PBM is available in Europe, Latin America, Singapore, the U.K., and the U.S. The transaction does not include the acquisition of AdaptDx and Nova/Diopsys diagnostic devices, which will be separated and spun off to LumiThera's shareholders before Alcon's acquisition and will continue to be marketed and sold by the LumiThera spin-off. Alcon and LumiThera anticipate the acquisition to be completed in the third quarter of 2025. Price Action: ALC stock is trading lower by 1.17% to $86.79 premarket, and STAA stock is trading higher by 44.9% to $26.78 at last check Tuesday. Read Next:Photo via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? STAAR SURGICAL (STAA): Free Stock Analysis Report This article Alcon Expands Vision Correction Portfolio With STAAR Surgical Acquisition originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 minutes ago
- Yahoo
Caterpillar projects tariffs could cost the company up to $1.5 billion in 2025
Caterpillar's operating profit margin and sales and revenue numbers fell in the second quarter of 2025 amid ongoing uncertainty and global economic changes sparked by President Donald Trump's tariff increases. Caterpillar CFO Andrew Bonfield told investors on a call Tuesday that the net impact of tariffs on Caterpillar this year will be between $1.3 billion and $1.5 billion. The Texas-based manufacturer, which has a heavy presence in the Peoria area, posted a 1% decrease in sales and revenues in Q2 compared to this time last year and a 2.6% decrease in operating profit margin. Profits per share fell to $4.62 in the second quarter compared to $5.48 last year. Adjusted profit shares were $4.72 this quarter, down from $5.99 last year. Caterpillar CEO Joe Creed said these numbers all met or went above Caterpillar's expectations for the quarter but told investors on the call that the impact of tariffs hit the high end of Caterpillar's estimates and the impact of tariffs on their numbers was expected to grow in the second half of the year. More: Why former CEO has 'confidence' Caterpillar will be in Peoria for 'a very long time' The Trump administration has been haphazardly negotiating trade deals with nations around the globe, many of which include increases in tariff rates on goods. They have been subject to change as the administration has changed the terms and numbers of deals as negotiations progress. Creed told investors on Tuesday that Caterpillar has deployed some "initial mitigation" efforts to curb the impact of tariffs but added the company is "considering all options" as they await more "sufficient certainty" on tariffs. In response to an investor question on the call, Creed said that Caterpillar's unique global supply chain has added complexity to the situation but he said Caterpillar is still waiting on more certainty and is still working to fully understand the latest tariff announcement from the government. On July 31, Trump signed an executive order that placed reciprocal tariffs on 70 countries at rates ranging from 15% to 41%. Those tariffs are expected to go into place on Aug. 7. Caterpillar's numbers were also lower in the first quarter of 2025 as tariffs have increased costs on the global manufacturer. In April, Creed told investors on a call that he expected tariffs to have a cost headwind of between $250 million and $350 million in Q2. Bonfield said Tuesday the tariff impact in the third quarter is expected to grow to $400 million to $500 million. Roughly 20% of the tariff impact will be on resource industries and 25% will be on transportation. The decrease in sales and revenues was because of "unfavorable price realization of $414 million," Caterpillar said. Despite the negative impact of tariffs, demand remains high and backlog at Caterpillar continues to grow, signaling positive markers for Caterpillar, Creed and Bonfield told investors on Tuesday. This article originally appeared on Journal Star: Caterpillar earnings fall in second quarter amid Trump tariff hikes